1. Home
  2. EDUC vs TPST Comparison

EDUC vs TPST Comparison

Compare EDUC & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Educational Development Corporation

EDUC

Educational Development Corporation

HOLD

Current Price

$1.30

Market Cap

13.1M

ML Signal

HOLD

Logo Tempest Therapeutics Inc.

TPST

Tempest Therapeutics Inc.

HOLD

Current Price

$0.98

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDUC
TPST
Founded
1965
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
15.6M
IPO Year
1995
2012

Fundamental Metrics

Financial Performance
Metric
EDUC
TPST
Price
$1.30
$0.98
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$11.00
AVG Volume (30 Days)
78.5K
1.8M
Earning Date
05-19-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
142.86
N/A
EPS
N/A
N/A
Revenue
$22,913,600.00
$295,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.20
$0.74
52 Week High
$1.73
$12.22

Technical Indicators

Market Signals
Indicator
EDUC
TPST
Relative Strength Index (RSI) 37.67 42.07
Support Level $1.29 N/A
Resistance Level $1.38 $1.09
Average True Range (ATR) 0.04 0.11
MACD -0.00 -0.01
Stochastic Oscillator 50.00 7.82

Price Performance

Historical Comparison
EDUC
TPST

About EDUC Educational Development Corporation

Educational Development Corp distributes books and educational products and publications through its PaperPie and EDC Publishing divisions to individual consumers, book, toy and gift stores, libraries and home educators located throughout the United States. The company is the owner and exclusive publisher of Kane Miller children's books; Learning Wrap-Ups, maker of educational manipulatives; and SmartLab Toys, maker of STEAM-based toys and games. It also the exclusive United States Multi-Level Marketing (MLM) distributor of Usborne Publishing Limited (Usborne) children's books. It sell children's books, educational toys and games and other related products. It has two reportable segments: PaperPie and Publishing of which majority of revenue comes from Paperpie.

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets. Company's small-molecule product candidate, amezalpat (previously known as TPST-1120), has completed a Phase 2 study in first-line hepatocellular carcinoma and the second small-molecule product candidate is TPST-1495, plans to initiate a Phase 2 study for in familial adenomatous polyposis.

Share on Social Networks: